Related references
Note: Only part of the references are listed.Optimising outcome on thiopurines in inflammatory bowel disease by co-prescription of allopurinol
Melissa A. Smith et al.
JOURNAL OF CROHNS & COLITIS (2012)
An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease
Nicholas J. Talley et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Clinical Usefulness of Therapeutic Drug Monitoring of Thiopurines in Patients with Inadequately Controlled Inflammatory Bowel Disease
Melissa L. Haines et al.
INFLAMMATORY BOWEL DISEASES (2011)
Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease
A. Ansari et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Combination of thiopurines and allopurinol: Adverse events and clinical benefit in IBD
Shail M. Govani et al.
JOURNAL OF CROHNS & COLITIS (2010)
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
A. Dignass et al.
JOURNAL OF CROHNS & COLITIS (2010)
Thiopurine therapy in inflammatory bowel disease
Christina Ha et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2010)
Long term efficacy and safety of allopurinol and azathioprine or 6-mercaptopurine in patients with inflammatory bowel disease
Yvette Leung et al.
JOURNAL OF CROHNS & COLITIS (2009)
Thiopurine dose in intermediate and normal metabolizers of thiopurine methyltransferase may differ three-fold
Sharon J. Gardiner et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
6-thioguanine nucleotide-adapted azathioprine therapy does not lead to higher remission rates than standard therapy in chronic active crohn disease:: results from a randomized, controlled, open trial
Max Reinshagen et al.
CLINICAL CHEMISTRY (2007)
Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine
Miles P. Sparrow et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: A meta-analysis
MT Osterman et al.
GASTROENTEROLOGY (2006)
American Gastroenterological Association institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease
GR Lichtenstein et al.
GASTROENTEROLOGY (2006)
6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease
MC Dubinsky et al.
GASTROENTEROLOGY (2002)
Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy
JF Colombel et al.
GASTROENTEROLOGY (2000)
Share Paper
